Clinical Trial Update: Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chidamide in combination with cladribine, gemcitabine, and busulfan plus autologous stem cell transplantation for relapsed/refractory d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• BUSULFAN (Busulfan)
• Chidamide (chidamide)
• Cladribine (cladribine)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Sichuan University | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN